DeviceTalks Podcast Network

AbbottTalks launches Season 3 with a fresh new video presence, a new co-host, and several new powerful conversations from Abbott's senior leaders. Host Tom Salemi and new co-host Kayleen Brown welcome Vish Charan, divisional vice president of product development for Abbott's Cardiac Rhythm Management, to explore the engineering evolution of the pacemaker—and where it’s headed next. Charan reflects on the remarkable transformation of pacemakers from large, wired implants to compact, leadless systems that dramatically improve patient outcomes. He details Abbott’s development of the AVEIR™ DR dual chamber leadless pacemaker system, the first of its kind to enable synchronized communication between the atrium and ventricle without leads, using Abbott’s proprietary i2i™ (implant-to-implant) technology. The conversation dives deep into conduction system pacing, modular upgrades, and how Abbott is shaping the future of cardiac care for millions of patients. The episode closes with a powerful story of a former professional surfer whose life was transformed by Abbott’s innovation—an example of technology enabling patients to reclaim their lives. Thank you to FPT Americas for sponsoring this episode of AbbottTalks. For more information on how FPT works with medical device companies, visit https://fptsoftware.com/  Thank you for listening to the AbbottTalks Podcast. Click here to subscribe on your favorite podcast player: https://abbotttalks.castos.com/subscribe.

In this debut episode of OlympusTalks, Host Tom Salemi welcomes Olympus Corporation of the Americas’ Vice President of Endoscopy Marketing Kurt Cannon, and colorectal cancer survivor and advocate Brooks Bell for a candid discussion on the importance of early screening. They explore Olympus’ role in advancing endoscopic technology and how it contributes to early detection and prevention of colon cancer.  Bell shares her personal experience with early-onset colorectal cancer, highlighting the urgent need to shift cultural perceptions around colonoscopies. She discusses her work through Worldclass Clothing, a nonprofit aimed at removing barriers to screening. Cannon elaborates on Olympus' commitment to improving adenoma detection rates and sheds light on how their latest innovation, the EVIS X1™ endoscopy system, is designed to support this mission. Colorectal cancer is rising in younger adults—but early screening can make all the difference. Tune in to hear how innovation, advocacy, and awareness are coming together to tackle colorectal cancer.   For more episodes by OlympusTalks, please visit http://olympusamerica.com/podcasts.  *Brooks Bell is a paid endorser of Olympus Corporation, its subsidiaries, and/or its affiliates. **The content of this podcast was paid for by Olympus. ADDITIONAL RESOURCES:  • To learn more about the EVIS X1™ Endoscopy System, visit https://medical.olympusamerica.com/products/evis-x1. • For resources on colorectal cancer screening and to read patient stories, visit https://www.colonoscopytoday.com/.   To follow OlympusTalks on your favorite podcast player and YouTube, please visit: https://olympustalks.castos.com/subscribe  Thank you for listening to the OlympusTalks podcast!

In this episode of Structural Heart Talks, Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, shares how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case. Nuzzolese explains how Edwards takes a "plan, make, source, deliver" approach, and why MedTech supply chains differ from consumer goods with a stronger emphasis on quality and availability. He details how the company strategically leverages dual sourcing, inventory buffering, and global distribution flexibility to maintain operations, even when borders close or suppliers face challenges. He also unpacks the need for automation and digital integration, explains how Edwards connects employees to patient outcomes to instill purpose, and reveals why fostering innovation readiness is central to their long-term strategy. Thank you to Daikin America for sponsoring this episode of Structural Heart Talks. To learn more about Daikin America’s products for your medical application visit https://daikin-america.com. Wait, there’s more! Want to learn more about Daikin America’s new Co-Extrusion technology? Click here for a high resolution image with more detail. Thank you for listening to the Structural Heart Talks podcast.  Subscribe to Structural Heart Talks or the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks on YouTube Podcasts to ensure you never miss an episode.

When a GI bleed strikes, the atmosphere in the procedure room changes instantly. In this episode of OlympusTalks, Olympus’ Christian Stroupe and Robert Barrett share how Olympus® technologies are designed to help physicians regain visibility and respond quickly to find the bleed and achieve hemostasis.  Chapter 1: Meet the Guests  Olympus’ Christian Stroupe and Robert Barrett explain their paths to medtech industry and their current roles in GI   Chapter 2: Why GI Bleeding Matters  The prevalence of GI bleeds and their impact on patient outcomes  Why it’s one of the top reasons for endoscopy  Chapter 3: The Moment Everything Changes  “You just see red everywhere” – how visibility is lost and urgency takes over  What it feels like when the room shifts from routine to critical  Chapter 4: Finding the Bleed  The challenge of pinpointing the source of the GI bleed  How advanced imaging helps physicians locate and assess the bleed  Chapter 5: Tools for Hemostasis  Overview of Olympus’ therapeutic options: clips, powders, and thermal forceps  Matching the right tool to the type of bleed  Chapter 6: Reducing Repeat Patient Visits  How effective hemostasis prevents rebleeds and follow-up procedures  Supporting physicians in getting it right the first time  Chapter 7: Hospital VS. ASC Settings  Difference in procedure complexity and patient profiles  Why even “routine” cases can present bleeding risks   For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts.  This podcast has been paid for by Olympus Corporation of the Americas.      ADDITIONAL RESOURCES:  Discover how the EVIS X1™ Endoscopy System is elevating the standard of care and the role of RDI™ technology: https://medical.olympusamerica.com/technology/rdi   Learn how EndoClot™ PHS, an advanced powder hemostat, supports physicians achieve hemostasis:   https://medical.olympusamerica.com/products/endoclotphs  Explore the Retentia™ HemoClip for reliable clipping and effective hemostasis during GI procedures:    https://medical.olympusamerica.com/products/retentia-hemoclip    *** Enjoy this podcast? Follow OlympusTalks on all major podcast players: https://olympustalks.castos.com/subscribe + Follow us on Yo... Chapters (00:01:18) - Meet the Guests(00:07:27) - Why GI Bleeding Matters(00:10:28) - Finding the Bleed(00:14:27) - The Moment Everything Changes(00:20:17) - Tools for Hemostasis(00:21:22) - Reducing Repeat Patient Visits(00:24:03) - Hospital VS. ASC Settings

In this week’s DeviceTalks Weekly, new Virtual Incision CEO Jim Alecxih walks us through his career, including a critical role at Intuitive Surgical, and explains why the Mira surgical robotic system convinced him to return to the industry. Olympus Ventures’ Abby Hunter-Syed keeps an eye on the broader tumult impacting MedTech. Chris Newmarker delivers the Newmarker’s Newsmakers – Insulet, Recor, Abbott, Ambu, GE Healthcare, Intuitive, Terumo and OrganOx. This episode is sponsored by DeviceTalks West. Check out the agenda and register at West.DeviceTalks.com. Thank you for listening to the DeviceTalks Podcast Network. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:50) - Show Open/Newmarker’s Newsmakers(00:05:25) - Insulet promotes Eric Benjamin to COO role(00:07:17) - Recor Medical's Paradise renal denervation tech wins Japanese approval(00:09:51) - Two Abbott MedTech executives leaving for new roles(00:13:03) - Intuitive announces layoffs?(00:16:35) - Terumo to acquire organ preservation device maker OrganOx for $1.5B(00:20:15) - FOMO – Abby Hunter-Syed, Sr. Director, Olympus Ventures(00:29:45) - Keynote – Jim Alecxih, CEO, Virtual Incision(00:37:07) - Early reactions to a surgical robot(00:42:40) - The Xbox /The Four Ps of Value Proposition(00:45:16) - Technology = Quality care(01:08:52) - Mira is different(01:10:12) - We're not a Ferrari. We’re an F150(01:14:57) - Message to patients

In this episode of DeviceTalks Weekly, Editorial Director Tom Salemi sits down with Ken Charhut, executive chair and CEO of Foldax, to discuss how the startup’s polymer valve and robotic manufacturing process could offer a new alternative to traditional structural heart valves. David Niewolny, director of healthcare and medical business development at NVIDIA, joins as this week’s FOMO guest to share his vision for the future of technology in MedTech. Managing Editor Kayleen Brown and Salemi highlight the expanding FOMO library, preview the 2025 MedTech Nerd Tour, and celebrate a major milestone for the DeviceTalks Podcast Network. Explore our collection here: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4994542/future-of-medtech-opportunities-fomo Finally, MassDevice Editor Chris Newmarker returns with his Newmarkers Newsmakers, covering Medtronic, Philips, renal denervation, NeuroOne, and Novocure. Thank you for listening to the DeviceTalks Podcast Network. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Ethan Korngold, MD, Divisional Vice President, Medical Affairs and Chief Medical Officer of Abbott’s Vascular business, to discuss how artificial intelligence is reshaping decision-making in the cath lab and beyond. Dr. Korngold, an interventional cardiologist turned MedTech leader, discusses the evolution of Abbott’s vascular portfolio and how the company is integrating AI through platforms like Ultreon 2.0 to improve outcomes and procedural efficiency. The conversation covers specific applications of AI in intravascular imaging, vessel sizing, calcium detection, and future steps in stent placement guidance. He also addresses physician and hospital system perceptions of AI, why he sees it as a GPS-like tool for guiding physicians through complex procedures, and how it may soon impact pre- and post-procedural care.  This episode is brought to you by Resonetics. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Want to understand the history of nitinol? Make sure to check out Eric's Veit's Nitinol Innovation: Decade-by-Decade breakdown on LinkedIn: https://www.linkedin.com/posts/eric-veit_nitinol-innovation-decade-by-decade-resonetics-activity-7358601495631552512-hm9D?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAB4aLUBXtw-TjMHSa4dOuAiKreGeEZCZM4 *** Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Intro + Ethan Korngold's MedTech background(00:05:14) - Abbott's Vascular Innovations and AI Integration in Healthcare(00:08:54) - Innovations in Nitinol for Medical Device Manufacturing(00:12:44) - AI Revolutionizes Vascular Procedures with Enhanced Decision-Making(00:19:47) - The Future of Nitinol in Medical and Technological Applications(00:24:04) - AI's Role in Enhancing Medical Procedures and Patient Outcomes(00:27:14) - Life-Saving Coronary Interventions and Advanced Imaging Techniques(00:29:24) - AI Revolutionizing Cath Lab Procedures and Patient Care

In this episode of the DeviceTalks Weekly Podcast, Subsense CEO and Co-Founder Tetiana Aleksandrova shares how her company is using nanoparticles to establish brain-computer interfaces with the potential to deliver powerful new therapies to the brain. In her conversation with Host Tom Salemi, she reflects on her background, the impact of the war in her native Ukraine, and her previous work on neural interfaces. Earlier in the episode, AcuityMD Co-Founder and CEO Michael Monovoukas offers a look at the future of MedTech innovation (FOMO) in a conversation with Managing Editor Kayleen Brown. This episode is brought to you by AcuityMD. Learn more at www.acuitymd.com. Also, Yvonne Bokelman, Executive Director of MedtechWOMEN, previews the upcoming MedtechVISION conference taking place Sept. 9. Register at MedtechWOMEN.org. Finally, MassDevice Editor Chris Newmarker delivers his Newmarkers Newsmakers, featuring updates on Modular Medical, SetPoint Medical, Boston Scientific, Nyxoah, and OpenAI. Thank you for listening to the DeviceTalks Weekly podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:20) - Newmarkers Newsmakers(00:06:21) - Modular Medical(00:08:18) - SetPoint Medical(00:10:14) - Boston Scientific(00:12:38) - Nyxoha(00:14:08) - OpenAI(00:16:22) - FOMO with Michael Monovoukas of AcuityMD(00:28:12) - Yvonne Bokelman, Executive Director, MedtechWOMEN(00:43:02) - Tetiana Aleksandrova, Co-Founder and CEO, Subsense(00:46:47) - Her origins/thoughts on the Russian invasion of her native Ukraine(00:52:18) - Origin of Subsense(00:56:20) - Nanoparticle technology(00:59:54) - Role of the nanoparticles

In this episode of the DeviceTalks Weekly podcast, iRhythm CEO Quentin Blackford shares his MedTech journey, the tech powering iRhythm’s arrhythmia detection, and what it takes to disrupt traditional healthcare. He talks patient engagement, predictive care, and the company’s push deeper into primary care. In this week’s FOMO, you’ll hear my interview with Zimmer Biomet CEO and President Ivan Tornos. We kick things off with MassDevice Editor Chris Newmarker’s Newmarker’s Newsmakers, covering Medtronic, Alcon, Staar Surgical, Inspire Medical, Edwards Lifesciences, and HistoSonics. Thanks for tuning in to DeviceTalks Weekly. *** Enjoy this episode? Follow DeviceTalks Weekly on your favorite podcast app and on YouTube.com/@DeviceTalks. Want full access to the DeviceTalks Podcast Network? Subscribe at https://devicetalks.castos.com/subscribe Chapters (00:02:04) - Newmarkers Newsmakers(00:06:10) - Medtronic(00:09:43) - Alcon(00:13:43) - Inspire Medical Systems(00:16:52) - Edwards Lifesciences(00:19:05) - HistoSonics(00:26:23) - FOMO Interview, Ivan Tornos, CEO & President, Zimmer Biomet(00:34:15) - Keynote Interview, Quentin Blackford, CEO, iRhythm(00:39:23) - Moving from CFO to CEO(00:42:43) - iRhythm overview(00:45:35) - What does profitability mean for a MedTech?(00:47:05) - Why does change take so long in healthcare?(00:51:00) - How do you engage with patients?(00:59:34) - Partnership with Lucem for predictive diagnostics(01:02:13) - Impact of Epic collaboration(01:06:57) - Importance of primary care physicians

In this episode of Ortho Innovation Talks, Terry Ross, Group President, Enovis™ Prevention & Recovery, shares how the company is reimagining orthopedic recovery through a combination of smart bracing technology and digital health platforms. Ross details how Enovis is prioritizing comfort and wearability in its bracing designs to drive better patient compliance, while also streamlining clinic operations through its MotionMD® workflow software. He also discusses MotionIQ®, a digital engagement tool designed to support patients throughout their rehab journey. With a focus on continuous improvement, Ross explains how Enovis is building connected solutions that improve patient outcomes and clinic efficiency—proving that externally applied devices can deliver powerful, tech-enabled care. This episode comes to you courtesy of our sponsor, Regenity. To learn more about how Regenity can help you 'make a material difference' please visit them at https://regenity.com. *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly podcast, MassDevice Editor Chris Newmarker speaks with Peter Menziuso, Johnson & Johnson company group chair for Vision, about the company’s strategy to advance vision care. J&J MedTech’s Vision business already represents one-sixth of the company’s $32 billion in annual medtech revenue, and new innovations are on the way to reach even more people with vision impairments. Recent launches include the Acuvue Oasys Max multifocal lens for astigmatism and the Tecnis Odyssey next-generation intraocular lens for cataract patients. This episode is sponsored by InterPower. Learn more at InterPower.com. Before that interview, DeviceTalks Managing Editor Kayleen Brown talks AI and diagnostics with Dennis Cheng, vice president of Cardiac Diagnostic Solutions at Boston Scientific, as part of our FOMO series. Newly minted Senior Editor Sean Whooley joins Newmarker and Host Tom Salemi to break down the week’s biggest headlines — including updates from Medtronic, Biotronik, CardioFocus, Cardiosense, and Dexcom. We’ll also review the new MassDevice Diabetes Technology Innovations Report. Thanks for listening to the DeviceTalks Weekly podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Infection preventionists are often the unsung heroes of patient safety—working behind the scenes to ensure that every procedure is as safe as possible. In this OlympusTalks episode, Jamie McGloin, Infection Prevention & Control Specialist at Olympus, and IPC consultant, Linda Dickey, bring their deep experience and unique perspectives to the forefront, offering a compelling look at the evolving role of IPs in GI endoscopy.  The episode explores practical aspects of medical device reprocessing, the importance of early collaboration between healthcare providers and manufacturers, and opportunities to improve consistency across the industry. From interpreting detailed IFUs to enhancing reprocessing workflows, Jamie and Linda highlight how infection preventionists are uniquely positioned to support safe and efficient patient care.  Listen now to learn how infection prevention is not just a background process—but a frontline defense in modern healthcare.  For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts.  * This podcast has been paid for by Olympus Corporation of the Americas. The views and experiences shared are those of Dr. Linda Dickey, a paid consultant of Olympus Corporation and its affiliates. Olympus makes no representations regarding the accuracy or applicability of the content and disclaims all liability arising from its use. Product performance may vary, and techniques, instruments, and clinical decisions are unique to each facility and practitioner. Always refer to the Instructions for Use and applicable labeling for guidance, risks, and cautions.  ADDITIONAL RESOURCES:  See how we can focus on infection prevention, together. Visit this page for additional resources, services, and tools to help support infection prevention at your facility: https://infectionprevention.olympus.com/en-us/  For infection preventionists looking to deepen their understanding of endoscope reprocessing, APIC’s resource offers evidence-based guidance and practical tools tailored to your role: https://apic.org/the-science-behind-endoscope-reprocessing/   *** Enjoy this podcast? Follow OlympusTalks on all major podcast players: https://olympustalks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi recaps highlights from this year’s Society of Robotic Surgeons annual meeting with surgical robotics leaders Steve Bell and Joe Mullings of The Mullings Group. The conversation dives into emerging trends in telesurgery and endovascular robotics—and takes a candid look at the blind spots still facing surgical robotics executives. Before that, Salemi speaks with Emily Stelzer, Senior Manager of Solutions Engineering at Tecan, about how medical device manufacturers can “future-proof” their operations in a landscape shaped by AI, shifting global trade policies, and evolving regulatory frameworks. Thank you to our episode sponsor, Tecan. Learn more at http://partnering.tecan.com/. And, as always, Chris Newmarker kicks things off with his Newmarker’s Newsmakers—this week featuring ZimVie, Dentsply Sirona, HeartFlow, Intuitive, and Boston Scientific. Thanks for listening to the DeviceTalks Weekly Podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this week’s episode of the DeviceTalks Weekly podcast, Host Tom Salemi looks ahead to DeviceTalks 2035 with Joe Urban, global president of Zimmer Biomet’s Knee Business. Urban, a military veteran and early Auris employee, shares insights on robotics, AI, and advancing ortho innovation. (Note: This interview was recorded before ZB’s announced acquisition of Monogram Technologies.) We open with Chris Newmarker’s Newsmakers, covering Abbott, Medtronic, Zimmer Biomet, Waters, BD, and Johnson & Johnson MedTech. In this week’s Future of MedTech Opportunities (FOMO) segment, Kurt Cannon, VP of Endoscopy Marketing at Olympus, discusses how ambulatory surgery centers are reshaping MedTech. This episode is brought to you by Cortland Biomedical. To discover why Cortland Biomedical is your trusted partner in biomedical textiles, visit https://www.cortlandbiomedical.com. Thanks for listening to the DeviceTalks Weekly Podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi hears encouraging news from Ken Mariash, CEO of Sinaptica Therapeutics, a neuromodulation company developing a TMS system that may be able to slow the advance of Azheimer’s. Mariash paints a hopeful picture for people - and families - fearing this dreadful disease. In our Future of MedTech Opportunities (FOMO) interview, DeviceTalks’ Emira Wininger talks with Heidi Dohse, founder and president of Tour de Heart. Dohse has used a pacemaker for nearly all of her life and brings important insights on the importance of patient design. This episode is brought to you by Interpower Corp. Go to Interpower.com for more information. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. *** Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi sits down with Rachel Ellingson, chief strategy and corporate development officer at Solventum, recorded live at DeviceTalks Minnesota. Ellingson shares a rare perspective on leading medical device companies through major transitions, drawing on her experience at Zimmer Biomet during the ZimVie spinout and now at the helm of a business spun out from 3M Healthcare. She compares the two experiences and outlines what’s ahead for Solventum. In our Future of MedTech Opportunities (FOMO) segment, Kayleen Brown speaks with Athar Mirza, VP of global infusion systems at Baxter International, about Baxter’s evolving role in connected health. This episode is brought to you by Protolabs, https://www.protolabs.com. Chris Newmarker and Sean Whooley break down the latest Newmarker’s Newsmakers, featuring headlines from Science, Olympus, Johnson & Johnson, and Stryker. Plus, Whooley shares insights from the American Diabetes Association meeting in Chicago, highlighting cutting-edge diabetes tech. Thanks for tuning in to the DeviceTalks Weekly Podcast. Enjoy this podcast? Follow DeviceTalks Weekly all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this insightful episode of the OlympusTalks podcast, Host Tom Salemi of DeviceTalks explores the powerful partnership between physicians and Clinical Applications Specialists (CAS) in the field of endoscopic ultrasound (EUS). Joining the conversation are gastroenterologist Dr. Julie Yang, an early adopter of EUS, and Melissa Elliott-Walker, a seasoned CAS with Olympus. Together, they unpack the critical role CASs play in supporting physicians—from training staff and optimizing imaging to supporting procedural outcomes and patient care. Dr. Yang shares how Melissa’s expertise helped elevate her practice from the ground up, describing EUS as “the truth” in diagnostic imaging. The episode dives into how EUS has evolved from a diagnostic tool to a therapeutic powerhouse, offering minimally invasive options for patients and playing a pivotal role in diagnosis and staging. Melissa brings her decades of experience in radiology and ultrasound to life, explaining how proximity and precision make EUS the gold standard for pancreatic imaging.1 She also introduces the emerging potential of shear wave elastography in liver diagnostics. For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts. * The views and experiences shared are those of Dr. Yang, a paid consultant of Olympus Corporation and its affiliates. Product performance may vary, and techniques, instruments, and clinical decisions are unique to each facility and practitioner. Potential complications that may be associated with endoscopic ultrasound include, but are not limited to, the following: sore throat, infection, bleeding, perforation, and/or tumor seeding (when EUS-FNA or FNB is performed). Salom, F., & Prat, F. (2022). Current role of endoscopic ultrasound in the diagnosis and management of pancreatic cancer. World journal of gastrointestinal endoscopy, 14(1), 35–48. https://doi.org/10.4253/wjge.v14.i1.35 Accessed July 2025. ADDITIONAL RESOURCE: Connect with your local CAS. They are ready to support your EUS practice and help you enhance patient care. For more information, visit: info.olympusamericamarketing.com/eus-cas *** Enjoy this podcast? Follow OlympusTalks on all major podcast players: https://olympustalks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Paul LaViolette, president and CEO of Pulse Biosciences. LaViolette takes us back to the early days of the medical device industry and shares how close collaboration with interventionalists helped shape today’s MedTech landscape. We dive into one of the biggest deals in MedTech history — Boston Scientific’s acquisition of Guidant — and why it was crucial for the company’s survival despite its rocky road. LaViolette also explains why investing in MedTech has never been more challenging and what drew him to lead Pulse Biosciences, a company pushing the boundaries of energy-based devices. Before that, we’re proud to launch our new Future of MedTech Opportunities (FOMO) series, sponsored by Protolabs, https://www.protolabs.com/. In this installment, we speak with Anthony Jarc, vice president of digital and machine learning at Intuitive. And as always, Chris Newmarker of Newmarker’s Newsmakers rounds up the biggest headlines, covering SS Innovations, Medtronic, Virtual Incision, and highlights from the American Diabetes Association’s annual meeting. Thanks for tuning in to DeviceTalks Weekly. Make sure to subscribe to the DeviceTalks Podcast Network so you never miss an episode: https://devicetalks.castos.com/subscribe

In this episode of Ortho Innovation Talks, Marc Mackey, senior vice president and general manager of Enabling Technologies at Enovis, breaks down how his team is building a next-generation platform that prioritizes precision, efficiency, and value. Mackey explains how augmented reality and AI are making orthopedic surgeries more accurate, efficient, and accessible — especially in outpatient environments like ASCs. He details the evolution of Enovis’ AR-based navigation platform, ARVIS, from early prototypes to its current compact, cost-effective design that eliminates the need for bulky hardware. As adoption grows, Mackey highlights how surgeons are leveraging ARVIS for soft tissue balancing, gap assessment, and patient-specific alignment, while AI streamlines surgical planning and imaging segmentation. This conversation comes to you courtesy of our sponsor, Regenity. To learn more about how Regenity can help support you, visit them at https://regenity.com. Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe.

In this podcast episode, MassDevice Editor Chris Newmarker sits down with Christian Mazzi, CEO of Corcym — formerly LivaNova’s surgical heart valve business — about how it has transformed since it became an independent company under Gyrus Capital in 2021. Next up is an effort to expand innovation beyond Corcym’s core heart valve portfolio to areas such as heart failure treatment. Mazzi, though, still has a lot to say about surgical heart valve replacement when speaking with MassDevice Editor in Chief Chris Newmarker. Surgical heart valve procedures are shifting toward being more laparoscopic, and surgical robotics applications are on the horizon. Even as transcatheter heart valves generate a lot of buzz in medtech, surgical heart valve innovation is getting exciting, too. Like the Arthurian heroes that Corcym names its products after, Mazzi and his company are on a quest. But first Host Tom Salemi, DeviceTalks Managing Editor Kayleen Brown and Newmarker share their highlights of the wildly successful DeviceTalks Minnesota that took place on June 11. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode. https://devicetalks.castos.com/subscribe